Press releases Image EN FR Corporate / 16.11.2022 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image FR EN Dosimetry / 24.10.2022 IBA Dosimetry expands its myQA® iON technology into Radiation Therapy Read more IBA Dosimetry expands its myQA® iON technology into Radiation Therapy
Press releases Image EN FR Dosimetry / 20.10.2022 IBA announces compatibility of its dosimetry solutions with Halcyon® and Ethos™ radiotherapy and adaptive therapy solutions Read more IBA announces compatibility of its dosimetry solutions with Halcyon® and Ethos™ radiotherapy and adaptive therapy solutions
Press releases Image EN FR RadioPharma Solutions / 13.10.2022 IBA expands its activities in Sub-Saharan Africa and signs contract with Sweden Ghana Medical Centre for an IntegraLab® PLUS in Accra, Ghana Read more IBA expands its activities in Sub-Saharan Africa and signs contract with Sweden Ghana Medical Centre for an IntegraLab® PLUS in Accra, Ghana
Press releases Image EN FR Corporate / 12.10.2022 IBA celebrates 35th [+1] anniversary with Belgian entrepreneurs and key players to commit to creating a leading sustainable Walloon region Read more IBA celebrates 35th [+1] anniversary with Belgian entrepreneurs and key players to commit to creating a leading sustainable Walloon region
Press releases Image EN FR Industrial Solutions / 06.10.2022 IBA signs contract for the first end-to-end Rhodotron® DUO solution for multi-purpose irradiation in Taiwan Read more IBA signs contract for the first end-to-end Rhodotron® DUO solution for multi-purpose irradiation in Taiwan
Press releases Image FR EN RadioPharma Solutions / 04.10.2022 ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia Read more ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia
Press releases Image EN FR RadioPharma Solutions / 22.09.2022 IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225 Read more IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225
Press releases Image EN FR Industrial Solutions / 20.09.2022 NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes Read more NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes
Reports Image EN FR Corporate / 01.09.2022 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2022 Read more UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2022
Press releases Image EN FR Proton Therapy / 01.09.2022 The PROTECT-trial consortium enrolls first patient into proton therapy study Read more The PROTECT-trial consortium enrolls first patient into proton therapy study
Press releases Image EN FR Corporate / 31.08.2022 IBA Reports Half Year 2022 Results Read more IBA Reports Half Year 2022 Results
Presentations Image EN Corporate / 31.08.2022 IBA Half Year Results 2022 Press release and presentation Read more IBA Half Year Results 2022 Press release and presentation
Press releases Image EN FR RadioPharma Solutions / 30.08.2022 CNRT and IBA sign collaboration agreement to install a Cyclone® IKON in China Read more CNRT and IBA sign collaboration agreement to install a Cyclone® IKON in China
Press releases Image EN FR Dosimetry / 30.08.2022 IBA and ScandiDos form strategic alliance to increase access to safe radiotherapy Read more IBA and ScandiDos form strategic alliance to increase access to safe radiotherapy
Press releases Image EN FR Proton Therapy / 26.08.2022 IBA qualifies as the only supplier for second round of tender to provide ten proton therapy units across Spain Read more IBA qualifies as the only supplier for second round of tender to provide ten proton therapy units across Spain
Press releases Image EN FR Proton Therapy / 18.08.2022 IBA and Apollo Proton Cancer Centre sign a collaboration agreement to provide proton therapy training and education programs in Asia Read more IBA and Apollo Proton Cancer Centre sign a collaboration agreement to provide proton therapy training and education programs in Asia
Press releases Image EN FR Proton Therapy / 02.08.2022 IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy Read more IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy
Press releases Image EN FR Corporate / 11.07.2022 IBA Notice of Half Year 2022 Results and Conference Call Read more IBA Notice of Half Year 2022 Results and Conference Call
Press releases Image FR EN Proton Therapy / 30.06.2022 IBA launches the ConformalFLASH® Alliance Read more IBA launches the ConformalFLASH® Alliance
